Mouse models of inherited lipodystrophy

DMM Disease Models and Mechanisms

Volumn 2, Issue 11-12, 2009, Pages 554-562

  Savage, David B ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; RECOMBINANT LEPTIN;

ANIMAL MODEL; CONTROLLED STUDY; DYSLIPIDEMIA; FATTY LIVER; GENETIC ENGINEERING; HYPERPHAGIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIPID STORAGE; LIPODYSTROPHY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SKELETAL MUSCLE; SPECIES DIFFERENCE;

ADIPOKINES; ANIMALS; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; HUMANS; INSULIN RESISTANCE; LIPODYSTROPHY; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; MUTATION; OBESITY; TRANSGENES;

MUS;

EID: 70549098559     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.002907     Document Type: Review

References (82)

1. Agarwal, A. K., Arioglu, E., De Almeida, S., Akkoc, N., Taylor, S. I., Bowcock, A. M., Barnes, R. I. and Garg, A. (2002). AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat. Genet. 31, 21-23. (Pubitemid 34887633)
2. Agostini, M., Schoenmakers, E., Mitchell, C., Szatmari, I., Savage, D., Smith, A., Rajanayagam, O., Semple, R., Luan, J., Bath, L. et al. (2006). Non-DNA binding, dominant-negative, human PPARgamma mutations cause lipodystrophic insulin resistance. Cell Metab. 4, 303-311. (Pubitemid 44430916)
3. Ahima, R. S., Prabakaran, D., Mantzoros, C., Qu, D., Lowell, B., Maratos-Flier, E. and Flier, J. S. (1996). Role of leptin in the neuroendocrine response to fasting. Nature 382, 250-252. (Pubitemid 26251358)
4. Asilmaz, E., Cohen, P., Miyazaki, M., Dobrzyn, P., Ueki, K., Fayzikhodjaeva, G., Soukas, A. A., Kahn, C. R., Ntambi, J. M., Socci, N. D. et al. (2004). Site and mechanism of leptin action in a rodent form of congenital lipodystrophy. J. Clin. Invest. 113, 414-424. (Pubitemid 38544185)
5. Asterholm, I. W., Halberg, N. and Scherer, P. E. (2007). Mouse models of lipodystrophy key reagents for the understanding of the metabolic syndrome. Drug Discov. Today Dis. Models 4, 17-24. (Pubitemid 350286531)
6. Barroso, I., Gurnell, M., Crowley, V. E., Agostini, M., Schwabe, J. W., Soos, M. A., Maslen, G. L., Williams, T. D., Lewis, H., Schafer, A. J. et al. (1999). Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402, 880-883. (Pubitemid 30017170)
7. Belfort, R., Harrison, S. A., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, A., Tio, F., Pulcini, J. et al. (2006). A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N. Engl. J. Med. 355, 2297-2307. (Pubitemid 44837778)
8. Berg, A. H., Combs, T. P. and Scherer, P. E. (2002). ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol. Metab. 13, 84-89. (Pubitemid 36740452)
9. Biddinger, S. B., Hernandez-Ono, A., Rask-Madsen, C., Haas, J. T., Aleman, J. O., Suzuki, R., Scapa, E. F., Agarwal, C., Carey, M. C., Stephanopoulos, G. et al. (2008). Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. Cell Metab. 7, 125-134. (Pubitemid 351168555)
10. Boutet, E., El Mourabit, H., Prot, M., Nemani, M., Khallouf, E., Colard, O., Maurice, M., Durand-Schneider, A. M., Chretien, Y., Gres, S. et al. (2009). Seipin deficiency alters fatty acid Delta9 desaturation and lipid droplet formation in Berardinelli-Seip congenital lipodystrophy. Biochimie 91, 796-803.
11. Brown, M. S. and Goldstein, J. L. (2008). Selective versus total insulin resistance: a pathogenic paradox. Cell Metab. 7, 95-96.
12. Cao, H. and Hegele, R. A. (2000). Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum. Mol. Genet. 9, 109-112. (Pubitemid 30145295)
13. Cho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., 3rd, Kaestner, K. H., Bartolomei, M. S., Shulman, G. I. and Birnbaum, M. J. (2001). Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292, 1728-1731.
14. Colombo, C., Cutson, J. J., Yamauchi, T., Vinson, C., Kadowaki, T., Gavrilova, O. and Reitman, M. L. (2002). Transplantation of adipose tissue lacking leptin is unable to reverse the metabolic abnormalities associated with lipoatrophy. Diabetes 51, 2727-2733. (Pubitemid 34970925)
15. Cortes, V. A., Curtis, D. E., Sukumaran, S., Shao, X., Parameswara, V., Rashid, S., Smith, A. R., Ren, J., Esser, V., Hammer, R. E. et al. (2009). Molecular mechanisms of hepatic steatosis and insulin resistance in the AGPAT2-deficient mouse model of congenital generalized lipodystrophy. Cell Metab. 9, 165-176.
16. Cutler, D. A., Sullivan, T., Marcus-Samuels, B., Stewart, C. L. and Reitman, M. L. (2002). Characterization of adiposity and metabolism in Lmna-deficient mice. Biochem. Biophys. Res. Commun. 291, 522-527. (Pubitemid 34687375)
17. Cypess, A. M., Lehman, S., Williams, G., Tal, I., Rodman, D., Goldfine, A. B., Kuo, F. C., Palmer, E. L., Tseng, Y. H., Doria, A. et al. (2009). Identification and importance of brown adipose tissue in adult humans. N. Engl. J. Med. 360, 1509-1517.
18. Danforth, E., Jr (2000). Failure of adipocyte differentiation causes type II diabetes mellitus? Nat. Genet. 26, 13.
19. Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D. and Parks, E. J. (2005). Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 115, 1343-1351. (Pubitemid 40629054)
20. Duan, S. Z., Ivashchenko, C. Y., Whitesall, S. E., D'Alecy, L. G., Duquaine, D. C., Brosius, F. C., 3rd, Gonzalez, F. J., Vinson, C., Pierre, M. A., Milstone, D. S. et al. (2007). Hypotension, lipodystrophy, and insulin resistance in generalized PPARgamma-deficient mice rescued from embryonic lethality. J. Clin. Invest. 117, 812-822.
21. Fei, W., Shui, G., Gaeta, B., Du, X., Kuerschner, L., Li, P., Brown, A. J., Wenk, M. R., Parton, R. G. and Yang, H. (2008). Fld1p, a functional homologue of human seipin, regulates the size of lipid droplets in yeast. J. Cell Biol. 180, 473-482. (Pubitemid 351240697)
22. Feldmann, H. M., Golozoubova, V., Cannon, B. and Nedergaard, J. (2009). UCP1 ablation induces obesity and abolishes diet-induced thermogenesis in mice exempt from thermal stress by living at thermoneutrality. Cell Metab. 9, 203-209.
23. Frayn, K. N. (2002). Adipose tissue as a buffer for daily lipid flux. Diabetologia 45, 1201-1210.
24. Garg, A. (2000). Gender differences in the prevalence of metabolic complications in familial partial lipodystrophy (Dunnigan variety). J. Clin. Endocrinol. Metab. 85, 1776-1782.
25. Garg, A. (2004). Acquired and inherited lipodystrophies. N. Engl. J. Med. 350, 1220-1234.
26. Garg, A., Fleckenstein, J. L., Peshock, R. M. and Grundy, S. M. (1992). Peculiar distribution of adipose tissue in patients with congenital generalized lipodystrophy. J. Clin. Endocrinol. Metab. 75, 358-361.
27. Garofalo, R. S., Orena, S. J., Rafidi, K., Torchia, A. J., Stock, J. L., Hildebrandt, A. L., Coskran, T., Black, S. C., Brees, D. J., Wicks, J. R. et al. (2003). Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. J. Clin. Invest. 112, 197-208. (Pubitemid 38056356)
28. Gavrilova, O., Marcus-Samuels, B., Graham, D., Kim, J. K., Shulman, G. I., Castle, A. L., Vinson, C., Eckhaus, M. and Reitman, M. L. (2000). Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J. Clin. Invest. 105, 271-278. (Pubitemid 30094446)
29. Gavrilova, O., Haluzik, M., Matsusue, K., Cutson, J. J., Johnson, L., Dietz, K. R., Nicol, C. J., Vinson, C., Gonzalez, F. J. and Reitman, M. L. (2003). Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J. Biol. Chem. 278, 34268-34276. (Pubitemid 37553270)
30. George, S., Rochford, J. J., Wolfrum, C., Gray, S. L., Schinner, S., Wilson, J. C., Soos, M. A., Murgatroyd, P. R., Williams, R. M., Acerini, C. L. et al. (2004). A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science 304, 1325-1328. (Pubitemid 38697429)
31. Ginsberg, H. N. (2000). Insulin resistance and cardiovascular disease. J. Clin. Invest. 106, 453-458.
32. Gray, S. L., Dalla Nora, E. and Vidal-Puig, A. J. (2005). Mouse models of PPAR-gamma deficiency: dissecting PPAR-gamma's role in metabolic homoeostasis. Biochem. Soc. Trans. 33, 1053-1058. (Pubitemid 41659112)
33. Gray, S. L., Nora, E. D., Grosse, J., Manieri, M., Stoeger, T., Medina-Gomez, G., Burling, K., Wattler, S., Russ, A., Yeo, G. S. et al. (2006). Leptin deficiency unmasks the deleterious effects of impaired peroxisome proliferator-activated receptor gamma function (P465L PPARgamma) in mice. Diabetes 55, 2669-2677. (Pubitemid 44923664)
34. Jackson, S. N., Howlett, T. A., McNally, P. G., O'Rahilly, S. and Trembath, R. C. (1997). Dunnigan-Kobberling syndrome: an autosomal dominant form of partial lipodystrophy. QJM 90, 27-36. (Pubitemid 27075849)
35. Kershaw, E. E. and Flier, J. S. (2004). Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 89, 2548-2556.
36. Kim, C. A., Delepine, M., Boutet, E., El Mourabit, H., Le Lay, S., Meier, M., Nemani, M., Bridel, E., Leite, C. C., Bertola, D. R. et al. (2008). Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy. J. Clin. Endocrinol. Metab. 93, 1129-1134. (Pubitemid 351540679)
37. Koutkia, P. and Grinspoon, S. (2004). HIV-associated lipodystrophy: pathogenesis, prognosis, treatment, and controversies. Annu. Rev. Med. 55, 303-317. (Pubitemid 38316729)
38. Lefterova, M. I. and Lazar, M. A. (2009). New developments in adipogenesis. Trends Endocrinol. Metab. 20, 107-114.
39. Linhart, H. G., Ishimura-Oka, K., DeMayo, F., Kibe, T., Repka, D., Poindexter, B., Bick, R. J. and Darlington, G. J. (2001). C/EBPalpha is required for differentiation of white, but not brown, adipose tissue. Proc. Natl. Acad. Sci. USA 98, 12532-12537. (Pubitemid 33019980)
40. Magre, J., Delepine, M., Khallouf, E., Gedde-Dahl, T., Jr, Van Maldergem, L., Sobel, E., Papp, J., Meier, M., Megarbane, A., Bachy, A. et al. (2001). Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat. Genet. 28, 365-370. (Pubitemid 32702427)
41. Medina-Gomez, G., Gray, S. L., Yetukuri, L., Shimomura, K., Virtue, S., Campbell, M., Curtis, R. K., Jimenez-Linan, M., Blount, M., Yeo, G. S. et al. (2007). PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet. 3, e64. (Pubitemid 46683479)
42. Mercier, I., Jasmin, J. F., Pavlides, S., Minetti, C., Flomenberg, N., Pestell, R. G., Frank, P. G., Sotgia, F. and Lisanti, M. P. (2009). Clinical and translational implications of the caveolin gene family: lessons from mouse models and human genetic disorders. Lab. Invest. 89, 614-623.
43. Misra, A. and Garg, A. (2003). Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature. Medicine (Baltimore) 82, 129-146. (Pubitemid 36331644)
44. Misra, A., Peethambaram, A. and Garg, A. (2004). Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature. Medicine (Baltimore) 83, 18-34. (Pubitemid 38124853)
45. Moitra, J., Mason, M. M., Olive, M., Krylov, D., Gavrilova, O., Marcus-Samuels, B., Feigenbaum, L., Lee, E., Aoyama, T., Eckhaus, M. et al. (1998). Life without white fat: a transgenic mouse. Genes Dev. 12, 3168-3181. (Pubitemid 28496262)
46. Oral, E. A., Simha, V., Ruiz, E., Andewelt, A., Premkumar, A., Snell, P., Wagner, A. J., DePaoli, A. M., Reitman, M. L., Taylor, S. I. et al. (2002). Leptin-replacement therapy for lipodystrophy. N. Engl. J. Med. 346, 570-578.
47. Pajvani, U. B., Trujillo, M. E., Combs, T. P., Iyengar, P., Jelicks, L., Roth, K. A., Kitsis, R. N. and Scherer, P. E. (2005). Fat apoptosis through targeted activation of caspase 8, a new mouse model of inducible and reversible lipoatrophy. Nat. Med. 11, 797-803. (Pubitemid 41021214)
48. Pardini, V. C., Victoria, I. M., Rocha, S. M., Andrade, D. G., Rocha, A. M., Pieroni, F. B., Milagres, G., Purisch, S. and Velho, G. (1998). Leptin levels, beta-cell function, and insulin sensitivity in families with congenital and acquired generalized lipoatropic diabetes. J. Clin. Endocrinol. Metab. 83, 503-508. (Pubitemid 28496530)
49. Payne, V. A., Grimsey, N., Tuthill, A., Virtue, S., Gray, S. L., Nora, E. D., Semple, R. K., O'Rahilly, S. and Rochford, J. J. (2008). The human lipodystrophy gene BSCL2/seipin may be essential for normal adipocyte differentiation. Diabetes 57, 2055-2060.
50. Petersen, K. F. and Shulman, G. I. (2002). Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus. Am. J. Cardiol. 90, 11G-18G.
51. Poitout, V. (2008). Glucolipotoxicity of the pancreatic beta-cell: myth or reality? Biochem. Soc. Trans. 36, 901-904.
52. Rankin, J. and Ellard, S. (2006). The laminopathies: a clinical review. Clin. Genet. 70, 261-274.
53. Razani, B., Engelman, J. A., Wang, X. B., Schubert, W., Zhang, X. L., Marks, C. B., Macaluso, F., Russell, R. G., Li, M., Pestell, R. G. et al. (2001). Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J. Biol. Chem. 276, 38121-38138. (Pubitemid 37384066)
54. Razani, B., Combs, T. P., Wang, X. B., Frank, P. G., Park, D. S., Russell, R. G., Li, M., Tang, B., Jelicks, L. A., Scherer, P. E. et al. (2002). Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities. J. Biol. Chem. 277, 8635-8647. (Pubitemid 34968330)
55. Reitman, M. L. (2002). Metabolic lessons from genetically lean mice. Annu. Rev. Nutr. 22, 459-482.
56. Reitman, M. L. and Gavrilova, O. (2000). A-ZIP/F-1 mice lacking white fat: a model for understanding lipoatrophic diabetes. Int. J. Obes. Relat. Metab. Disord. 24 Suppl. 4, S11-S14.
57. Reue, K. and Phan, J. (2006). Metabolic consequences of lipodystrophy in mouse models. Curr. Opin. Clin. Nutr. Metab. Care 9, 436-441. (Pubitemid 44097814)
58. Rodeheffer, M. S., Birsoy, K. and Friedman, J. M. (2008). Identification of white adipocyte progenitor cells in vivo. Cell 135, 240-249.
59. Rosen, E. D., Sarraf, P., Troy, A. E., Bradwin, G., Moore, K., Milstone, D. S., Spiegelman, B. M. and Mortensen, R. M. (1999). PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell 4, 611-617. (Pubitemid 29531140)
60. Ross, S. R., Graves, R. A. and Spiegelman, B. M. (1993). Targeted expression of a toxin gene to adipose tissue: transgenic mice resistant to obesity. Genes Dev. 7, 1318-1324. (Pubitemid 23210881)
61. Savage, D. B., Tan, G. D., Acerini, C. L., Jebb, S. A., Agostini, M., Gurnell, M., Williams, R. L., Umpleby, A. M., Thomas, E. L., Bell, J. D. et al. (2003). Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma. Diabetes 52, 910-917. (Pubitemid 36384259)
62. Savage, D. B., Petersen, K. F. and Shulman, G. I. (2007). Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol. Rev. 87, 507-520. (Pubitemid 47084679)
63. Seip, M. and Trygstad, O. (1996). Generalized lipodystrophy, congenital and acquired (lipoatrophy). Acta Paediatr. Suppl. 413, 2-28. (Pubitemid 26189575)
64. Semple, R. K., Chatterjee, V. K. and O'Rahilly, S. (2006). PPAR gamma and human metabolic disease. J. Clin. Invest. 116, 581-589. (Pubitemid 43326862)
65. Semple, R. K., Sleigh, A., Murgatroyd, P. R., Adams, C. A., Bluck, L., Jackson, S., Vottero, A., Kanabar, D., Charlton-Menys, V., Durrington, P. et al. (2009). Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis. J. Clin. Invest. 119, 315-322.
66. Shackleton, S., Lloyd, D. J., Jackson, S. N., Evans, R., Niermeijer, M. F., Singh, B. M., Schmidt, H., Brabant, G., Kumar, S., Durrington, P. N. et al. (2000). LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat. Genet. 24, 153-156. (Pubitemid 30094715)
67. Shimomura, I., Hammer, R. E., Richardson, J. A., Ikemoto, S., Bashmakov, Y., Goldstein, J. L. and Brown, M. S. (1998). Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev. 12, 3182-3194. (Pubitemid 28496263)
68. Shimomura, I., Hammer, R. E., Ikemoto, S., Brown, M. S. and Goldstein, J. L. (1999). Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 401, 73-76. (Pubitemid 29418444)
69. Shimomura, I., Matsuda, M., Hammer, R. E., Bashmakov, Y., Brown, M. S. and Goldstein, J. L. (2000). Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol. Cell 6, 77-86.
70. Shulman, G. I. (2000). Cellular mechanisms of insulin resistance. J. Clin. Invest. 106, 171-176.
71. Simha, V. and Garg, A. (2003). Phenotypic heterogeneity in body fat distribution in patients with congenital generalized lipodystrophy caused by mutations in the AGPAT2 or seipin genes. J. Clin. Endocrinol. Metab. 88, 5433-5437. (Pubitemid 37452750)
72. Spiegelman, B. M. and Flier, J. S. (2001). Obesity and the regulation of energy balance. Cell 104, 531-543.
73. Sullivan, T., Escalante-Alcalde, D., Bhatt, H., Anver, M., Bhat, N., Nagashima, K., Stewart, C. L. and Burke, B. (1999). Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J. Cell Biol. 147, 913-920.
74. Szymanski, K. M., Binns, D., Bartz, R., Grishin, N. V., Li, W. P., Agarwal, A. K., Garg, A., Anderson, R. G. and Goodman, J. M. (2007). The lipodystrophy protein seipin is found at endoplasmic reticulum lipid droplet junctions and is important for droplet morphology. Proc. Natl. Acad. Sci. USA 104, 20890-20895.
75. Tan, G. D., Savage, D. B., Fielding, B. A., Collins, J., Hodson, L., Humphreys, S. M., O'Rahilly, S., Chatterjee, K., Frayn, K. N. and Karpe, F. (2008). Fatty acid metabolism in patients with PPARgamma mutations. J. Clin. Endocrinol. Metab. 93, 4462-4470. (Pubitemid 352789548)
76. Tansey, J. T., Sztalryd, C., Gruia-Gray, J., Roush, D. L., Zee, J. V., Gavrilova, O., Reitman, M. L., Deng, C. X., Li, C., Kimmel, A. R. et al. (2001). Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc. Natl. Acad. Sci. USA 98, 6494-6499. (Pubitemid 32488265)
77. Taylor, S. I., Cama, A., Accili, D., Barbetti, F., Quon, M. J., de la Luz Sierra, M., Suzuki, Y., Koller, E., Levy-Toledano, R., Wertheimer, E. et al. (1992). Mutations in the insulin receptor gene. Endocr. Rev. 13, 566-595.
78. Tsai, Y. S., Kim, H. J., Takahashi, N., Kim, H. S., Hagaman, J. R., Kim, J. K. and Maeda, N. (2004). Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARgamma. J. Clin. Invest. 114, 240-249. (Pubitemid 39071629)
79. van Marken Lichtenbelt, W. D., Vanhommerig, J. W., Smulders, N. M., Drossaerts, J. M., Kemerink, G. J., Bouvy, N. D., Schrauwen, P. and Teule, G. J. (2009). Coldactivated brown adipose tissue in healthy men. N. Engl. J. Med. 360, 1500-1508.
80. Virtanen, K. A., Lidell, M. E., Orava, J., Heglind, M., Westergren, R., Niemi, T., Taittonen, M., Laine, J., Savisto, N. J., Enerback, S. et al. (2009). Functional brown adipose tissue in healthy adults. N. Engl. J. Med. 360, 1518-1525.
81. Wang, N. D., Finegold, M. J., Bradley, A., Ou, C. N., Abdelsayed, S. V., Wilde, M. D., Taylor, L. R., Wilson, D. R. and Darlington, G. J. (1995). Impaired energy homeostasis in C/EBP alpha knockout mice. Science 269, 1108-1112.
82. Wojtanik, K. M., Edgemon, K., Viswanadha, S., Lindsey, B., Haulzik, M., Chen, W., Poy, G., Reitman, M. and Londos, C. (2009). The role of LMNA in adipose: a novel mouse model of lipodystrophy based on the Dunnigan's partial lipodystrophy mutation. J. Lipid Res. 50, 1068-1079.